Mayukh Sukhatme, President & CIO at Roivant Sciences Ltd. (ROIV), sold 651,558 shares at $26.47 ($17.2M) on 2026-02-09, disclosed to the SEC on 2026-02-11.
Open-market sale of $17.2M ROIV by President & CIO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.47 | 312,117 | $8.3M | 47.9% |
| 2 | $26.47 | 339,441 | $9.0M | 52.1% |
| Total | $26.47 avg | 651,558 | $17.2M | 100% |
| Filing → |
| ROIV | SELL | 2026-06-29 | $34.1M | — | Filing → |
| ROIV | SELL | 2025-12-31 | $57.8M | — | Filing → |
| ROIV | SELL | 2025-12-19 | $1.2M | — | Filing → |